Atara Biotherapeutics (ATRA) Earnings Date, Estimates & Call Transcripts

Atara Biotherapeutics logo
$6.33 -0.01 (-0.16%)
As of 11/20/2026 04:00 PM Eastern

Atara Biotherapeutics Earnings Summary

Atara Biotherapeutics posted Q3 2026 earnings on November 10, 2026, reporting an EPS of -$0.15, which missed the consensus estimate of -$0.13 by $0.02. Quarterly revenue was reported to be $1.22 million, above analyst estimates of $800 thousand. With a trailing EPS of -$1.01, Atara Biotherapeutics' earnings are expected to grow next year, from ($0.22) to $1.38 per share.

Latest Q3
Earnings Date
Nov. 10Estimated
Consensus EPS
(Nov. 10)
-$0.13
Actual EPS
(Nov. 10)
-$0.15 Missed By -$0.02
Actual Revenue
(Nov. 10)
$1.22M

Q3 2026 Earnings Resources

Get Atara Biotherapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Atara Biotherapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ATRA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ATRA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Atara Biotherapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261$2.46$2.46$2.46
Q2 20261-$0.57-$0.57-$0.57
Q3 20261-$0.52-$0.52-$0.52
Q4 20261-$0.49-$0.49-$0.49
FY 20264$0.88$0.88$0.88

Atara Biotherapeutics Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/10/2026Q3 2026-$0.1328-$0.15 -$0.0172-$0.15$0.80M$1.22M
8/12/2026Q2 2026-$0.3150-$0.32 -$0.0050-$0.32$0.55M$0.63M
5/12/2026Q1 2026-$0.3295-$0.29+$0.0395-$0.29$2.90M$0.52M
3/16/2026Q4 2025-$0.68-$0.25+$0.43-$0.36$0.70M$1.60M
11/12/2025Q3 2025-$0.83-$0.32+$0.51-$0.32$2.74M$3.45M
8/11/2025Q2 2025-$0.32$0.19+$0.51$0.19$4.23M$17.58M
5/15/2025Q1 2025-$3.07$3.50+$6.57$3.50$4.30M$98.10M
3/7/2025Q4 2024-$3.82-$1.19+$2.63-$1.19$20.58M$32.75M

Atara Biotherapeutics Earnings - Frequently Asked Questions

Atara Biotherapeutics (NASDAQ:ATRA) last announced its quarterly earning data on Tuesday, November 10, 2026. Learn more on ATRA's earnings history.

In the previous quarter, Atara Biotherapeutics (NASDAQ:ATRA) missed the analysts' consensus estimate of ($0.13) by $0.02 with a reported earnings per share (EPS) of ($0.15). Learn more on analysts' earnings estimate vs. ATRA's actual earnings.

Atara Biotherapeutics (NASDAQ:ATRA) has a recorded annual revenue of $120.77 million.

Atara Biotherapeutics (NASDAQ:ATRA) has a recorded net income of $32.69 million. ATRA has generated -$1.01 earnings per share over the last four quarters.

Atara Biotherapeutics' earnings are expected to grow from ($0.22) per share to $1.38 per share in the next year.


Earnings data for NASDAQ:ATRA is sourced from Fiscal.ai, with the most recent quarter reported on 11/10/2026. New results are added as companies report their earnings.
From Our Partners